The National Pharmacovigilance Committee in Mauritius was established in December 2011 and Mauritius became a full member of the WHO Programme for International Drug Monitoring in 2014. It functions to manage and address any potential safety and quality issues that could arise from the use of health products marketed in Mauritius.
How to report?
Send to:
National Pharmacovigilance Committee 10th Floor, Emmanuel Anquetil Building Port-Louis
E-Mail: phcovigilmru@govmu.org
https://youtu.be/gq6l-s1NxG4